Ahmed S Al Askar (Ahmed Alaskar, Ahmed AlAskar, Ahmed S Alaskar)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Bone marrow transplantation

American journal of hematology

JCO global oncology

JMIR research protocols

King Abdullah International Medical Research Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King Abdullah International Medical Research Center

Saudi Arabia

Exexutive Director

King Saud bin Abdulaziz University for Health Sciences

Saudi Arabia

Associate Professor :: College of Medicine

King Abdulaziz Medical City

Saudi Arabia

Consultant & Head Division :: Oncology, Adult Hematology & HSCT

Publications

Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Mazin Ahmed, Tahani Alanazi, Rasha Ahmed, Amani Alharbi, Inaam Shehabeddine, Afnan Alzaidi, Suha Alkhuraisat, Isam Mahassnah, Hamza Alquraan, Maybelle Ballili, Mohsen Alzahrani
Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients. American journal of hematology (2024)
Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Mazin Ahmed, Tahani Alanazi, Rasha Ahmed, Amani Alharbi, Inaam Shehabeddine, Afnan Alzaidi, Suha Alkhuraisat, Isam Mahassnah, Hamza Alquraan, Maybelle Ballili, Mohsen Alzahrani
Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients. American journal of hematology 99 (6) (2024)
Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Mazin Ahmed, Tahani Alanazi, Rasha Ahmed, Amani Alharbi, Inaam Shehabeddine, Afnan Alzaidi, Suha Alkhuraisat, Isam Mahassnah, Hamza Alquraan, Maybelle Ballili, Mohsen Alzahrani
Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients. American journal of hematology 99 (6) (2024)
Moussab Damlaj, Mohamed Tlayjeh, Ahmad Damlaj, Bader Alahmari, Husam AlSadi, Mazin Ahmed, Zied AlJubour, Ayman Alhejazi, Hend Salama, Ayman Ibrahim, Abdulrahman Al Raizah, Mohammed Bakkar, Abdulraouf Ghori, Abdullah S Al Saleh, Ahmed S Al Askar, Mohsen Al Zahrani
Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world. Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Florent Malard, Florent Malard, Ahmed S Al Askar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Fréderic Baron, Ali Bazarbachi, Didier Blaise, Eolia Brissot, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Anne Huynh, Michelle Kenyon, Arnon Nagler, Antonio Pagliuca, Zinaida Perić, Paul Gerard Richardson, Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub Agha, Rafael F Duarte, Enric Carreras
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone marrow transplantation (2023)
Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Inaam Shehab-Eddine, Abdulrahman Alghamdi, Walid Almashaqbeh, Heba Alshobaki, Isam Mahasneh, Ashwaq Alotaibi, Tahany Alanazi, Maybelle Balili, Mohammed Quarshi, Mazin Ahmed, Mohsen Al Zahrani
Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease. Bone marrow transplantation 57 (2) (2022)
Abdullah S Al Saleh, Abdulrahman I Alghamdi, Mohsen Al Zahrani, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Husam Alsadi, Suha Alkhraisat, Inaam Shehab-Eddine, Moussab Damlaj
Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis. Bone marrow transplantation 57 (7) (2022)
Khadega A Abuelgasim, Moussab Damlaj, Mohammad Bosaeed, Sumayyah Altamimi, Hind Abdullah, Reem M Ramli, Rahma Alzahrani, Nourah Alzughaibi, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Mohsen Al Zahrani
Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation. Bone marrow transplantation 56 (12) (2021)
Mohsen Al Zahrani, Moussab Damlaj, Mohammed F Essa, Bader Alahmari, Ahmed S Al Askar, Ayman Hejazi, Enas Basher, Husam Alsadi, Mazin Ahmed, Rodaina Abujoub, Samer Ghazi, Heba Alshobaki, Khadega A Abuelgasim, Hind Salama, Giamal Gmati, Abdulrahman Alsultan
HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome. Bone marrow transplantation (2021)
Bader Alahmari, Mohsen Alzahrani, Nawal Al Shehry, Osamah Tawfiq, Turki Alwasaidi, Ayman Alhejazi, Mohammed Bakkar, Amal Al Behainy, Mansour Radwi, Ahmed S Al Askar
Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation. JCO global oncology 7 (2021)
Moussab Damlaj, Khadega A Abuelgasim, Ayman Alhejazi, Bader Alahmari, Ahmed S Al Askar, Mohsen Alzahrani
Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone marrow transplantation 55 (12) (2020)
Mohammed Albalawi, Syed Ziauddin Ahmed Zaidi, Nawal Faiez AlShehry, Ahmed S Al Askar, Abdul Rehman Zia Zaidi, Rania Nagib Mohammed Abdallah, Ahmed AlSagheir, Nour AlMozain, Ghada Elgohary, Khalid Batarfi, Alia Alfaraedi, Osamah Khojah, Rehab Y Al-Ansari, Mona Alfaraj, Afra Dayel, Ahmed Al Bahrani, Arwa Nabhan Abdelhameed, Hind Alhumaidan, Jawaher M Al-Otaibi, Ghazala Radwi, Abdulrahman Raizah, Hind Shatry, Sara Alsaleh, Hazzaa AlZahrani, Hani Al Hashmi
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study. JMIR research protocols 9 (10) (2020)
Khadega A Abuelgasim, Mohsen Alzahrani, Yousef Alsharhan, Moataz Khairi, Mohammed Hommady, Giamal Gmati, Hind Salama, Osama Ali, Bader Alahmari, Emad M Masuadi, Ahmed S Al Askar, Ayman Alhejazi, Moussab Damlaj
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone marrow transplantation 54 (7) (2019)
Moussab Damlaj, Ahmed S Al Askar, Samer Ghazi, Bader Alahmari, Ayman Alhejazi, Mohsen Al-Zahrani
Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective. Bone marrow transplantation 53 (10) (2018)
Ahmed S Al Askar, Naila A Shaheen, Mohsen Al Zahrani, Mohammed G Al Otaibi, Bader S Al Qahtani, Faris Ahmed, Mohand Al Zughaibi, Ismat Kamran, May Anne Mendoza, Altaf Khan
Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience. International journal of hematology 107 (1) (2017)

Ahmed S Al Askar.css-eqlu8i{font-size:small;padding-left:4px;} (Ahmed Alaskar, Ahmed AlAskar, Ahmed S Alaskar)

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmed S Al Askar (Ahmed Alaskar, Ahmed AlAskar, Ahmed S Alaskar)